LBRX
LBRX
US50180M1080
LB Pharmaceuticals Inc
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.2B EUR
930.84M EUR
707.12M EUR
563.16M EUR
Enterprise Value
793.92M EUR
652.95M EUR
389.92M EUR
316.56M EUR
Valuation Multiples
Trailing P/E
372.2x
--
--
--
Forward P/E
-7.2x
--
--
--
Price to Sales
--
--
--
--
Price to Book
3.21x
2.8x
1.87x
1.87x
EV/Revenue
--
--
--
--
EV/EBITDA
-8.72x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-4.49%
-8.9%
-7.13%
-4.81%
ende